Septmeber 30, 2004 NT 10-QSB

SECURITIES AND EXCHANGE COMMISSION
WASHINGTION, DC 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

Commission File No. 000-32917


| |  Form 10-K    |  |   Form 20-F    |  |   Form 11-K    | X|   Form 10-QSB    |  |   Form N-SAR

For the period ended: September 30, 2004

|  | Transition Report on Form 10-K
|  | Transition Report on Form 20-F
|  | Transition Report on Form 11-K
|  | Transition Report on Form 10-Q
|  | Transition Report on Form N-SAR

       For the transition period ended:

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification related to a portion of the filing checked above, identify the item(s) to which notification relates:


Part I-Registrant Information 

 
Full name of Registrant:                                                                                                     ProtoKinetix, Inc.
Address of Principal Executive Office:                                                                            1500-885 West Georgia Street
City, State and Zip Code:                                                                                                   Vancouver, BC V6C 3E8
Canada    


 
     

 

Part II-Rule 12b-25(b) and (c) 
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.(Check box if appropriate.)
 
        (a)  The reasons described in detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
|X|    (b)  The subject annual report, semi-annual report, transition report of Forms 10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before
the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, 10-QSB, or portion thereof will be filed on or before the 5th calendar day following the prescribed due date; and
 
(c)  The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 

 
     

 

Part III-Narrative 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.

The Registrant has been unable to compile all pertinent information to complete the quarterly filing or complete providing the Registrant's accountant with all of the accounting information necessary to complete the quarterly report. The September 30, 2004 quarterly report could not be completed without unreasonable effort or expense.

The Registrant anticipates that it will file its Form 10-QSB within the five-day grace period provided by Exchange Act Rule 12b-25.

 
     

 

Part IV-Other Information 

(1)    Name and telephone number of person to contact in regard to this notification:
 
Dr. John Todd                     604-687-9887
(Name) (Area Code) (Telephone Number)
 
(2)    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?
|X|   Yes   |  |   No
If the answer is no, identify report(s)
     
(3)    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

|  |   Yes   |X|   No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 
     

 

ProtoKinetix, Inc.
Name of Registrant as Specified in Charter

Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 15, 2004    By:  /s/ John Todd
                         Dr. John Todd,
                                                                         Chief Executive Officer